Other Clinical Trial - Raltitrexed Concurrent With Radiotherapy for

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Carcinoma
Carcinoma, Squamous Cell
Esophageal Neoplasms
Esophageal Squamous Cell Carcinoma
Esophagus Squamous Cell Carcinoma

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03712566` - Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy
Recruiting	`NCT04018872` - Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer	Phase 2
Recruiting	`NCT05865132` - Palbociclib Combined With Afatinib for Advanced Squamous Carcinoma of Esophagus or Gastroesophageal Junction	Phase 2

See also

Status

Clinical Trial

Phase

Active, not recruiting

NCT03712566 - Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy

Recruiting

NCT04018872 - Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Phase 2

Recruiting

NCT05865132 - Palbociclib Combined With Afatinib for Advanced Squamous Carcinoma of Esophagus or Gastroesophageal Junction

Phase 2

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03585530
Study type	Interventional
Source	Huai'an First People's Hospital
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	September 5, 2018
Completion date	March 15, 2022

Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms